CIK 0001816736
- Large accelerated filer
Disc Medicine, Inc.
Sign in to watch- Ticker
- IRON
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 851612845
- Phone
- +1 617-674-9274
- Business address
- 321 ARSENAL STREET, SUITE 101, WATERTOWN, MA, 02472
- Former names
- Gemini Therapeutics, Inc. /DE, FS Development Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $11,877,065
- in 6 filings, $10.0M under 10b5-1 plans
Net −$11,877,065. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 32 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-16 | Quisel John D Chief Executive Officer | Sale 10b5-1 | −6,305 | $66.35 | $418K | 72,565 |
| 2024-12-16 | Quisel John D Chief Executive Officer | Sale 10b5-1 | −500 | $67.20 | $34K | 72,065 |
| 2024-12-16 | Quisel John D Chief Executive Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −12,791 | 225,420 | ||
| 2024-12-02 | White William Richard Director | Option exercise 10b5-1 | +1,756 | $2.65 | $5K | 1,756 |
| 2024-12-02 | White William Richard Director | Option exercise 10b5-1 | +201 | $9.86 | $2K | 1,957 |
| 2024-12-02 | White William Richard Director | Sale 10b5-1 | −22 | $63.49 | $1K | 1,935 |
| 2024-12-02 | White William Richard Director | Sale 10b5-1 | −1,762 | $64.58 | $114K | 173 |
| 2024-12-02 | White William Richard Director | Sale 10b5-1 | −173 | $65.33 | $11K | 0 |
| 2024-12-02 | White William Richard Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,756 | 0 | ||
| 2024-12-02 | White William Richard Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −201 | 1,804 | ||
| 2024-11-25 | Savage William Jacob Chief Medical Officer | Option exercise 10b5-1 | +5,263 | $9.86 | $52K | 45,668 |
| 2024-11-25 | Savage William Jacob Chief Medical Officer | Option exercise 10b5-1 | +8,920 | $13.50 | $120K | 54,588 |
| 2024-11-25 | Savage William Jacob Chief Medical Officer | Sale 10b5-1 | −8,737 | $64.98 | $568K | 45,851 |
| 2024-11-25 | Savage William Jacob Chief Medical Officer | Sale 10b5-1 | −3,542 | $65.79 | $233K | 42,309 |
| 2024-11-25 | Savage William Jacob Chief Medical Officer | Sale 10b5-1 | −1,904 | $67.02 | $128K | 40,405 |
| 2024-11-25 | Savage William Jacob Chief Medical Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,263 | 5,258 | ||
| 2024-11-25 | Savage William Jacob Chief Medical Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −8,920 | 30,004 | ||
| 2024-11-15 | Savage William Jacob Chief Medical Officer | Option exercise 10b5-1 | +9,158 | $9.86 | $90K | 49,563 |
| 2024-11-15 | Savage William Jacob Chief Medical Officer | Sale 10b5-1 | −7,839 | $59.54 | $467K | 41,724 |
| 2024-11-15 | Savage William Jacob Chief Medical Officer | Sale 10b5-1 | −1,219 | $60.16 | $73K | 40,505 |
Page 18 of 32 · 639 trades